166 related articles for article (PubMed ID: 1658998)
1. Lithium and the phosphoinositide cycle: an example of uncompetitive inhibition and its pharmacological consequences.
Nahorski SR; Ragan CI; Challiss RA
Trends Pharmacol Sci; 1991 Aug; 12(8):297-303. PubMed ID: 1658998
[TBL] [Abstract][Full Text] [Related]
2. Beryllium competitively inhibits brain myo-inositol monophosphatase, but unlike lithium does not enhance agonist-induced inositol phosphate accumulation.
Faraci WS; Zorn SH; Bakker AV; Jackson E; Pratt K
Biochem J; 1993 Apr; 291 ( Pt 2)(Pt 2):369-74. PubMed ID: 8387266
[TBL] [Abstract][Full Text] [Related]
3. Inhibitors of inositol monophosphatase.
Fauroux CM; Freeman S
J Enzyme Inhib; 1999; 14(2):97-108. PubMed ID: 10445037
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of an enzyme displaying both inositol-polyphosphate-1-phosphatase and 3'-phosphoadenosine-5'-phosphate phosphatase activities: a novel target of lithium therapy.
Patel S; Yenush L; Rodríguez PL; Serrano R; Blundell TL
J Mol Biol; 2002 Jan; 315(4):677-85. PubMed ID: 11812139
[TBL] [Abstract][Full Text] [Related]
5. Regulation of inositol monophosphatase in Saccharomyces cerevisiae.
Murray M; Greenberg ML
Mol Microbiol; 1997 Aug; 25(3):541-6. PubMed ID: 9302016
[TBL] [Abstract][Full Text] [Related]
6. Lithium and the brain: a psychopharmacological strategy to a molecular basis for manic depressive illness.
Lenox RH; Watson DG
Clin Chem; 1994 Feb; 40(2):309-14. PubMed ID: 8313612
[TBL] [Abstract][Full Text] [Related]
7. Phosphoinositide deficiency due to inositol depletion is not a mechanism of lithium action in brain.
Berry GT; Buccafusca R; Greer JJ; Eccleston E
Mol Genet Metab; 2004 May; 82(1):87-92. PubMed ID: 15110328
[TBL] [Abstract][Full Text] [Related]
8. Electroconvulsive shock stimulates polyphosphoinositide degradation and inositol trisphosphate accumulation in rat cerebrum: lithium pretreatment does not potentiate these changes.
Vadnal RE; Bazan NG
Neurosci Lett; 1987 Sep; 80(1):75-9. PubMed ID: 2821459
[TBL] [Abstract][Full Text] [Related]
9. Dictyostelium discoideum contains three inositol monophosphatase activities with different substrate specificities and sensitivities to lithium.
Van Dijken P; Bergsma JC; Hiemstra HS; De Vries B; Van Der Kaay J; Van Haastert PJ
Biochem J; 1996 Mar; 314 ( Pt 2)(Pt 2):491-5. PubMed ID: 8670062
[TBL] [Abstract][Full Text] [Related]
10. Effects of L-690,488, a prodrug of the bisphosphonate inositol monophosphatase inhibitor L-690,330, on phosphatidylinositol cycle markers.
Atack JR; Prior AM; Fletcher SR; Quirk K; McKernan R; Ragan CI
J Pharmacol Exp Ther; 1994 Jul; 270(1):70-6. PubMed ID: 8035344
[TBL] [Abstract][Full Text] [Related]
11. Chronically administered lithium alters neither myo-inositol monophosphatase activity nor phosphoinositide levels in rat brain.
Honchar MP; Ackermann KE; Sherman WR
J Neurochem; 1989 Aug; 53(2):590-4. PubMed ID: 2545823
[TBL] [Abstract][Full Text] [Related]
12. Lithium-induced teratogenesis in frog embryos prevented by a polyphosphoinositide cycle intermediate or a diacylglycerol analog.
Busa WB; Gimlich RL
Dev Biol; 1989 Apr; 132(2):315-24. PubMed ID: 2538373
[TBL] [Abstract][Full Text] [Related]
13. Acute and chronic lithium treatments influence agonist and depolarization-stimulated inositol phospholipid hydrolysis in rat cerebral cortex.
Kendall DA; Nahorski SR
J Pharmacol Exp Ther; 1987 Jun; 241(3):1023-7. PubMed ID: 3037063
[TBL] [Abstract][Full Text] [Related]
14. Comparative effects of lithium on the phosphoinositide cycle in rat cerebral cortex, hippocampus, and striatum.
Jenkinson S; Patel N; Nahorski SR; Challiss RA
J Neurochem; 1993 Sep; 61(3):1082-90. PubMed ID: 8395558
[TBL] [Abstract][Full Text] [Related]
15. Effects of lithium on phosphoinositide metabolism in vivo.
Sherman WR; Gish BG; Honchar MP; Munsell LY
Fed Proc; 1986 Oct; 45(11):2639-46. PubMed ID: 3019784
[TBL] [Abstract][Full Text] [Related]
16. Agonist-induced desensitization of muscarinic receptor-mediated calcium efflux without concomitant desensitization of phosphoinositide hydrolysis.
Masters SB; Quinn MT; Brown JH
Mol Pharmacol; 1985 Mar; 27(3):325-32. PubMed ID: 2983182
[TBL] [Abstract][Full Text] [Related]
17. Disruption by lithium of phosphoinositide signalling in cerebellar granule cells in primary culture.
del Río E; Shinomura T; van der Kaay J; Nicholls DG; Downes CP
J Neurochem; 1998 Apr; 70(4):1662-9. PubMed ID: 9523584
[TBL] [Abstract][Full Text] [Related]
18. Myo-inositol monophosphatase: diverse effects of lithium, carbamazepine, and valproate.
Vadnal R; Parthasarathy R
Neuropsychopharmacology; 1995 Jul; 12(4):277-85. PubMed ID: 7576004
[TBL] [Abstract][Full Text] [Related]
19. Evidence for coupling of resynthesis to hydrolysis in the phosphoinositide cycle.
Monaco ME; Adelson JR
Biochem J; 1991 Oct; 279 ( Pt 2)(Pt 2):337-41. PubMed ID: 1659375
[TBL] [Abstract][Full Text] [Related]
20. Age-related differences in the phosphoinositide system in rat neostriatum.
DasGupta K; Weiler MH
Neuropsychopharmacology; 1992 Sep; 7(2):163-5. PubMed ID: 1329801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
